Section 413 (a) of the Federal Food,
drug and Cosmetic Act (the Act) (21 U.S.C. 350b(a)) provides that
at least 75 days before the introduction or delivery for
introduction into interstate commerce of a dietary supplement that
contains a new dietary ingredient, a manufacturer or distributor of
dietary supplements or of a new dietary ingredient is to submit to
FDA (as delegate for the Scretary of Health and Human Services)
information upon which the manufacturer or distributor has based
its conclusion that a dietary supplement containing a new dietary
ingredient will reasonably be expected to be safe. Part 190 (21 CFR
part 190) implements these statutory provisions. Section 190.6 (a)
requires each manufacturer or distributor of a dietary supplement
containing a new dietary ingredient, or of a new dietary ingredient
, to submit to the Office of Nutrition, Labeling and Dietary
Supplements notification of the basis for their conclusion that
said supplement or ingredient will reasonably be expected to be
safe. Section 190.6(b) specifies what information the notification
must include.
On behalf of this Federal agency, I certify that
the collection of information encompassed by this request complies
with 5 CFR 1320.9 and the related provisions of 5 CFR
1320.8(b)(3).
The following is a summary of the topics, regarding
the proposed collection of information, that the certification
covers:
(i) Why the information is being collected;
(ii) Use of information;
(iii) Burden estimate;
(iv) Nature of response (voluntary, required for a
benefit, or mandatory);
(v) Nature and extent of confidentiality; and
(vi) Need to display currently valid OMB control
number;
If you are unable to certify compliance with any of
these provisions, identify the item by leaving the box unchecked
and explain the reason in the Supporting Statement.